Global Fabrazyme (agalsidase beta) Market Growth 2019-2024

Published On: Jan 2019

Format: PDF

Publisher: LP Infomation

Pages: 130

Report ID: 224782

Fabrazyme® (agalsidase beta) is used to treat patients with Fabry disease. Fabrazyme lowers the amount of a substance called globotriaosylceramide (GL-3), which builds up in cells lining the blood vessels of the kidney and certain other cells.

According to this study, over the next five years the Fabrazyme (agalsidase beta) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Fabrazyme (agalsidase beta) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Fabrazyme (agalsidase beta) market by product type, application, key manufacturers and key regions and countries.

This study considers the Fabrazyme (agalsidase beta) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
5mg/vial
35mg/vial
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Genzyme Corporation
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Fabrazyme (agalsidase beta) consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Fabrazyme (agalsidase beta) market by identifying its various subsegments.
Focuses on the key global Fabrazyme (agalsidase beta) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Fabrazyme (agalsidase beta) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Fabrazyme (agalsidase beta) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Fabrazyme (agalsidase beta) Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fabrazyme (agalsidase beta) Consumption 2013-2023
2.1.2 Fabrazyme (agalsidase beta) Consumption CAGR by Region
2.2 Fabrazyme (agalsidase beta) Segment by Type
2.2.1 5mg/vial
2.2.2 35mg/vial
2.3 Fabrazyme (agalsidase beta) Consumption by Type
2.3.1 Global Fabrazyme (agalsidase beta) Consumption Market Share by Type (2013-2018)
2.3.2 Global Fabrazyme (agalsidase beta) Revenue and Market Share by Type (2013-2018)
2.3.3 Global Fabrazyme (agalsidase beta) Sale Price by Type (2013-2018)
2.4 Fabrazyme (agalsidase beta) Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Fabrazyme (agalsidase beta) Consumption by Application
2.5.1 Global Fabrazyme (agalsidase beta) Consumption Market Share by Application (2013-2018)
2.5.2 Global Fabrazyme (agalsidase beta) Value and Market Share by Application (2013-2018)
2.5.3 Global Fabrazyme (agalsidase beta) Sale Price by Application (2013-2018)

3 Global Fabrazyme (agalsidase beta) by Players
3.1 Global Fabrazyme (agalsidase beta) Sales Market Share by Players
3.1.1 Global Fabrazyme (agalsidase beta) Sales by Players (2016-2018)
3.1.2 Global Fabrazyme (agalsidase beta) Sales Market Share by Players (2016-2018)
3.2 Global Fabrazyme (agalsidase beta) Revenue Market Share by Players
3.2.1 Global Fabrazyme (agalsidase beta) Revenue by Players (2016-2018)
3.2.2 Global Fabrazyme (agalsidase beta) Revenue Market Share by Players (2016-2018)
3.3 Global Fabrazyme (agalsidase beta) Sale Price by Players
3.4 Global Fabrazyme (agalsidase beta) Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Fabrazyme (agalsidase beta) Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Fabrazyme (agalsidase beta) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Fabrazyme (agalsidase beta) by Regions
4.1 Fabrazyme (agalsidase beta) by Regions
4.1.1 Global Fabrazyme (agalsidase beta) Consumption by Regions
4.1.2 Global Fabrazyme (agalsidase beta) Value by Regions
4.2 Americas Fabrazyme (agalsidase beta) Consumption Growth
4.3 APAC Fabrazyme (agalsidase beta) Consumption Growth
4.4 Europe Fabrazyme (agalsidase beta) Consumption Growth
4.5 Middle East & Africa Fabrazyme (agalsidase beta) Consumption Growth

5 Americas
5.1 Americas Fabrazyme (agalsidase beta) Consumption by Countries
5.1.1 Americas Fabrazyme (agalsidase beta) Consumption by Countries (2013-2018)
5.1.2 Americas Fabrazyme (agalsidase beta) Value by Countries (2013-2018)
5.2 Americas Fabrazyme (agalsidase beta) Consumption by Type
5.3 Americas Fabrazyme (agalsidase beta) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Fabrazyme (agalsidase beta) Consumption by Countries
6.1.1 APAC Fabrazyme (agalsidase beta) Consumption by Countries (2013-2018)
6.1.2 APAC Fabrazyme (agalsidase beta) Value by Countries (2013-2018)
6.2 APAC Fabrazyme (agalsidase beta) Consumption by Type
6.3 APAC Fabrazyme (agalsidase beta) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Fabrazyme (agalsidase beta) by Countries
7.1.1 Europe Fabrazyme (agalsidase beta) Consumption by Countries (2013-2018)
7.1.2 Europe Fabrazyme (agalsidase beta) Value by Countries (2013-2018)
7.2 Europe Fabrazyme (agalsidase beta) Consumption by Type
7.3 Europe Fabrazyme (agalsidase beta) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Fabrazyme (agalsidase beta) by Countries
8.1.1 Middle East & Africa Fabrazyme (agalsidase beta) Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Fabrazyme (agalsidase beta) Value by Countries (2013-2018)
8.2 Middle East & Africa Fabrazyme (agalsidase beta) Consumption by Type
8.3 Middle East & Africa Fabrazyme (agalsidase beta) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Fabrazyme (agalsidase beta) Distributors
10.3 Fabrazyme (agalsidase beta) Customer

11 Global Fabrazyme (agalsidase beta) Market Forecast
11.1 Global Fabrazyme (agalsidase beta) Consumption Forecast (2018-2023)
11.2 Global Fabrazyme (agalsidase beta) Forecast by Regions
11.2.1 Global Fabrazyme (agalsidase beta) Forecast by Regions (2018-2023)
11.2.2 Global Fabrazyme (agalsidase beta) Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Fabrazyme (agalsidase beta) Forecast by Type
11.8 Global Fabrazyme (agalsidase beta) Forecast by Application

12 Key Players Analysis
12.1 Genzyme Corporation
12.1.1 Company Details
12.1.2 Fabrazyme (agalsidase beta) Product Offered
12.1.3 Genzyme Corporation Fabrazyme (agalsidase beta) Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Genzyme Corporation News
...

13 Research Findings and Conclusion